AKT1 and cancer: Interestingly, resistance to mTOR inhibitors in TNBC was accompanied by the appearance of Notch-dependent cancer stem-like cells (CSCs) [138], suggesting that Notch inhibitors may be combined with mTOR/AKT inhibitors.